Pediatric trauma center levels serial#

Demographic data were extracted from patient charts after discharge, including date of admission, date of discharge, body mass index (BMI), admission diagnosis, race, ethnicity, date and time of LabHb and SpHb, device number, perfusion index (PI-which is the вЂњratio of pulsatile blood flow to nonpulsatile or static blood flowвЂќ ) measured by the device, oxygen saturation (SpO 2), mode of ventilation or oxygen support, body temperature, heart rate, mean arterial pressure, Richmond Agitation and Sedation Score, the use of vasopressors, and the LabHb result. Consent forms and Health Insurance Portability and Accountability Act research authorization forms were obtained by a member of the research team. Parents or legal guardians of eligible patients were provided with an information sheet regarding the study. Also patients weighing less than 3 kg were excluded.ДЄt the time of admission to the PICU, attending physicians, nurses, or advanced care providers determined whether patients met inclusion criteria. Patients were excluded if they did not have exposed fingers or toes because of congenital anomalies, wound dressings, or another injury. Pediatric patients (aged 30 dвЂ“18 y), who required hospitalization in the PICU with Hb monitoring during the 3 month enrollment period, were eligible for the study. The present study examines the use of the Masimo Pronto SpHb Monitor, the agreement with LabHb levels in critically ill children in a busy tertiary care setting, as a first step in ultimately determining the clinical utility of the monitor in this patient population.Дў.1.

Pediatric trauma center levels serial#

However, if the accuracy of the device could be demonstrated in critically ill children, the PICU would provide an ideal setting for the use of SpHb given the need for serial monitoring in a large number of patients to address the challenges specific to pediatric patients. However, the data regarding its use and implementation in critically ill children are sparse as there is only a single study examining the use of Masimo technology in a Pediatric Intensive Care Unit (PICU). Previous studies done in pediatric patients have found вЂњacceptableвЂќ agreement between SpHb and LabHb in the outpatient, preoperative, and operating room settings. The focus of these studies has been the degree of agreement between the SpHb and laboratory Hb (LabHb). One of these monitors is the Masimo Pronto SpHb Monitor (Masimo Corporation, Irvine, CA).Д«efore and since the time of Food and Drug Administration approval, several studies have examined the use of SpHb in neonates, children, and adults. In an effort to provide rapid and cost-effective Hb analysis, noninvasive hemoglobin (SpHb) devices have been developed and approved by the FDA. These challenges, and the traumatizing nature of venipuncture laboratory draws in children, are balanced with a clinicianвЂ™s desire to avoid unnecessary laboratory blood draws and medical tests.

When compared to adults, serial Hb monitoring presents unique challenges specific to the pediatric population, including: anemia from repeated blood draws, difficulties with venous access, and decreased patient cooperation with blood draws.

Critically ill pediatric patients frequently require hemoglobin (Hb) monitoring.